Evidence map›Paper›PMID 41788336›Full record

ArticleFrontiers in microbiology2026

Basecalling-free resistance gene identification using a hybrid transformer in raw nanopore signals.

Roman Jakubicek, Jevhenij Vorochta, Marketa Jakubickova, Matej Bezdicek, Martina Lengerova, Helena Vitkova

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roman JakubicekDepartment of Biomedical Engineering, Brno University of Technology, Brno, Czechia.
Jevhenij VorochtaDepartment of Biomedical Engineering, Brno University of Technology, Brno, Czechia.
Marketa JakubickovaDepartment of Biomedical Engineering, Brno University of Technology, Brno, Czechia.
Matej BezdicekDivision of Clinical Microbiology and Immunology, Department of Laboratory Medicine, University Hospital Brno, Brno, Czechia.
Martina LengerovaDivision of Clinical Microbiology and Immunology, Department of Laboratory Medicine, University Hospital Brno, Brno, Czechia.
Helena VitkovaDepartment of Biomedical Engineering, Brno University of Technology, Brno, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanopore sequencing enables real-time access to raw signal data, which brings new possibilities for rapid genomic diagnostics. However, current workflows still primarily rely on basecalling, a computationally intensive step that slows subsequent analysis and limits real-time use. In addition, most current approaches that work with raw signals focus on simple read-level classification tasks and are not designed to detect and localize specific genes, particularly complex genomic features such as antibiotic resistance genes (ARGs). Here, we show that the hybrid convolutional-transformer model, NanoResFormer, can detect clinically relevant ARGs directly from raw nanopore signals without basecalling. The model captures both local and long-range signal patterns and employs a floating-window strategy to process inputs of varying lengths efficiently. In proof-of-concept experiments, NanoResFormer achieved a sensitivity of 92.6% and a precision of over 93%, with short latency, enabling real-time resistome profiling already during sequencing. The proposed approach, therefore, provides rapid access to crucial information, accelerating decision-making in clinical diagnostics and pathogen surveillance.

Indexed as

antimicrobial resistanceconvolutional encoderfloating window approachKlebsiella pneumoniaereal-time detectionself-attention modelsquiggle

Identifiers

PMID41788336
PMCPMC12957220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.